Feb 19, 2026, 01:01 AM by User Not Found

Bio-IT World | During the Clinical Trial Venture, Innovation, and Partnering event at this year’s SCOPE, Deloitte Consulting’s 2026 Life Sciences Executive Outlook revealed in a presentation that 75% of 280 surveyed C-suite executives across pharma and medtech expressed a positive or cautiously positive outlook. Yet beneath that headline lies a sharp transatlantic divide.

Feb 19, 2026, 01:00 AM by User Not Found

Bio-IT World | During the Clinical Trial Venture, Innovation, and Partnering event at this year’s SCOPE, Deloitte Consulting’s 2026 Life Sciences Executive Outlook revealed in a presentation that 75% of 280 surveyed C-suite executives across pharma and medtech expressed a positive or cautiously positive outlook. Yet beneath that headline lies a sharp transatlantic divide.

Feb 18, 2026, 20:49 PM by

Feb 18, 2026, 20:49 PM by

Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathology

Feb 17, 2026, 01:00 AM by User Not Found

Bio-IT World | Repetitive head acceleration events (RHAEs) are repeated impacts that rapidly move the head and can cause concussions and brain damage. Yet current interventions remain reactive, focused on rest and symptom management after injury, rather than preventing microscopic damage that accumulates over time. A new study from the University of Utah Health has found an unconventional approach: photobiomodulation (PBM), or red light therapy.

Feb 13, 2026, 08:20 AM by

Feb 12, 2026, 11:44 AM by User Not Found

Bio-IT World | Anything that can be defined as a system—a mixed-bag list that includes physical materials like silicon and graphene as well as patient-specific implantable devices and the human brain—are subject to the law of entropy, meaning its disorder irreversibly increases over time if left alone. It turns out that this fundamental concept has a more comprehensive approach, dubbed zentropy by its creators at Penn State.

Feb 11, 2026, 01:01 AM by User Not Found

Bio-IT World | For decades, the industry’s approach to treating high blood pressure has centered on various organs—the heart, kidneys, and blood vessels. A new study suggests that this strategy may address downstream effects rather than the root cause. The primary driver of hypertension in a majority of patients may reside in the brain.

Feb 10, 2026, 09:45 AM by

Feb 10, 2026, 09:45 AM by

Feb 10, 2026, 01:01 AM by User Not Found

Bio-IT World | After a turbulent few years for biotechnology, investors and entrepreneurs are recalibrating. That shift was the main topic of conversation in the most recent Trends from the Trenches episode, with John Keilty, venture partner at Third Rock Ventures, and host Eleanor Howe, founder and CEO of Diamond Age Data Science.

Feb 9, 2026, 07:42 AM by

Feb 9, 2026, 07:42 AM by

New module streamlines standardized CRF (case report form) design and EDC build to help clinical teams start studies faster.

Feb 6, 2026, 07:26 AM by

Feb 6, 2026, 01:01 AM by User Not Found

Bio-IT World | For decades, the role of statistical programmers in drug development was clearly defined. They were responsible for producing validated tables, listings, and figures from clinical trial data, most often using statistical analysis systems, within structured workflows for regulatory submissions. That model is now under pressure.

Feb 4, 2026, 07:51 AM by

Cirena has announced its public launch following successful delivery of high-quality long RNA to leading academic and pharmaceutical research teams across the U.S., Europe, and Japan.

Feb 4, 2026, 07:51 AM by

Feb 3, 2026, 16:00 PM by User Not Found

Bio-IT World | Yesterday, PacBio announced the completion of the sale of short-read DNA sequencing technology to Illumina. PacBio received $48.1 million in net cash proceeds from the transaction. The sale closed on January 30, 2026.

Feb 3, 2026, 01:01 AM by User Not Found

Bio-IT World | It has been known for some time now that for people with irregular sleep patterns, including shift workers and frequent travelers across time zones, disruptions to the body’s circadian rhythm can be deadly. The dangers have notably included heightened risk of aggressive breast cancer.

Jan 30, 2026, 08:41 AM by